‘‘Subtitle C—Response 
‘‘Sec. 2131. First responder guidance concerning chemical, biological, radio-
logical, and nuclear attacks. 
‘‘Sec. 2132. Integrated plume modeling for collective response. 
‘‘Sec. 2133. Establishment of the system assessment and validation for emer-
gency responders (SAVER) program. 
‘‘Sec. 2134. Payment for laboratory response services. 
‘‘Sec. 2135. Bioforensics capabilities. 
‘‘Sec. 2136. Metropolitan Medical Response System Program. 
‘‘Subtitle D—Recovery 
‘‘Sec. 2141. Identifying and addressing gaps in recovery capabilities. 
‘‘Sec. 2142. Recovery from a chemical, biological, radiological, and nuclear 
attack or incident. 
‘‘Sec. 2143. Exercises. 
Sec. 302. Enhancing laboratory biosecurity. 
Sec. 303. Definitions. 
Sec. 304. Dual-use terrorist risks from synthetic biology. 
Sec. 305. Dissemination of information analyzed by the Department to State, 
local, tribal, and private entities with responsibilities relating to 
homeland security. 
TITLE IV—PUBLIC HEALTH MATTERS 
Sec. 401. Sense of Congress regarding Federal coordination on medical counter-
measures. 
Sec. 402. National Medical Countermeasure Dispensing Strategy. 
‘‘Sec. 319F–5. National Medical Countermeasure Dispensing Strategy. 
Sec. 403. National pre-event vaccination and antimicrobial dispensing policy re-
view. 
Sec. 404. Management of short shelf life vaccine and antimicrobial stockpiles. 
Sec. 405. Material threat determinations reviews. 
Sec. 406. Background checks. 
Sec. 407. State, local, and tribal defined. 
TITLE V—FOREIGN RELATIONS MATTERS 
Sec. 501. International engagement to enhance biodefense and laboratory biosecu-
rity. 
Sec. 502. International collaboration and information sharing relating to biosecu-
rity. 
Sec. 503. Interagency task force on best practices for global biopreparedness. 
Sec. 504. Biological and Toxin Weapons Convention. 
SEC. 2. DEFINITIONS. 
In this Act: 
(1) The term ‘‘appropriate congressional com-
mittees’’ means the Committee on Homeland Security 
of the House of Representatives and any committee of 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
the House of Representatives or the Senate having leg-
islative jurisdiction under the rules of the House of 
Representatives or Senate, respectively, over the mat-
ter concerned. 
(2) The term ‘‘Intelligence Community’’ has the 
meaning given that term in section 3(4) of the Na-
tional Security Act of 1947 (50 U.S.C. 401a(4)). 
(3) The term ‘‘national biosecurity and bio-
defense stakeholders’’ means officials from the Federal, 
State, local, and tribal authorities and individuals 
and other persons from the private sector who are in-
volved in efforts to prevent, protect against, respond 
to, and recover from a biological attack or other phe-
nomena that may have serious health consequences for 
the United States, including wide-scale fatalities or 
infectious disease outbreaks. 
TITLE I—A NATIONAL 
BIODEFENSE ENTERPRISE 
SEC. 101. SPECIAL ASSISTANT FOR BIODEFENSE. 
(a) IN GENERAL.—The President shall assign a mem-
ber of the National Security Council to serve as Special As-
sistant to the President for Biodefense, who shall— 
(1) serve as the principal advisor to the Presi-
dent regarding coordination of Federal biodefense pol-
icy including prevention, protection, response, and re-
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
covery from biological attacks or other phenomena 
that may have serious health consequences for the 
United States, including wide-scale fatalities or infec-
tious disease outbreaks; 
(2) identify gaps, duplication, and other ineffi-
ciencies in existing biodefense activities and the ac-
tions necessary to overcome these obstacles; 
(3) lead the development of a coordinated Na-
tional Biodefense Plan, in accordance with section 
102; 
(4) lead the development of a coordinated Na-
tional Biosurveillance Strategy, in accordance with 
section 103; 
(5) lead the development of a coordinated na-
tional research and development strategy and imple-
mentation plan for microbial forensics, the latter to 
be updated not less than once every 4 years; 
(6) oversee, in coordination with the Director of 
the Office of Management and Budget, the develop-
ment of a comprehensive cross-cutting biodefense 
budget analysis to inform prioritization of resources 
and ensure that biodefense challenges are adequately 
addressed, in accordance with section 104; and 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
(7) conduct ongoing oversight and evaluation of 
implementation of Federal biodefense activities by rel-
evant Government departments and agencies. 
(b) ACCESS BY CONGRESS.—The appointment of the 
Special Assistant to the President for Biodefense shall not 
be construed as affecting access by Congress or committees 
of either House of Congress to information, documents, and 
studies in the possession of, or conducted by or at the direc-
tion of, the Special Assistant. 
SEC. 102. NATIONAL BIODEFENSE PLAN. 
The Special Assistant to the President for Biodefense 
shall submit to the President a National Biodefense Plan 
that— 
(1) defines the scope and purpose of a national 
biodefense capability; 
(2) identifies biological risks to the Nation to be 
addressed by the Plan, consistent with section 2102 of 
the Homeland Security Act of 2002, as amended by 
this Act; 
(3) delineates activities and tasks to be per-
formed, including prevention, protection, response, 
and recovery activities, to address the risks identified 
under paragraph (2); 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
(4) defines research and development needs for 
improving the capacity for threat awareness and pre-
vention, protection, response, and recovery; 
(5) identifies biodefense assets, interdependencies, 
capability gaps, and gaps in the integration of capa-
bilities; 
(6) provides goals, activities, milestones, and 
performance measures; 
(7) identifies resource and investment needs; 
(8) defines organizational roles, responsibilities , 
and coordination of Federal, State, local, and tribal 
authorities (as those terms are defined in the Home-
land Security Act of 2002 (6 U.S.C. 101 et seq.)) with 
respect to the activities and tasks delineated in para-
graph (3); 
(9) integrates and supports the strategies out-
lined in Presidential Policy Directives 2 and 8 and 
Homeland Security Presidential Directives 5, 9, 10, 
18, 21, and their successors, the National Biosurveil-
lance Strategy published under section 103 of this 
Act, the National Medical Countermeasure Dispensing 
Strategy developed under section 319F–5 of the Public 
Health Service Act, as amended by this Act, and 
other strategy documents as appropriate; 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
(10) is consistent with the National Response 
Framework as published by the Secretary of Home-
land Security in January 2008, and any successors 
thereof; 
(11) incorporates input from Federal, State, 
local, and tribal stakeholders; 
(12) provides planning guidance to biosecurity 
and biodefense stakeholders, including leveraging of 
existing guidance; and 
(13) shall be submitted to the President and the 
Congress within 18 months after the date of the enact-
ment of this Act, and updated as necessary. 
SEC. 103. NATIONAL BIOSURVEILLANCE STRATEGY. 
(a) STRATEGY FOR BIOSURVEILLANCE.—The Special 
Assistant to the President for Biodefense shall publish a Na-
tional Biosurveillance Strategy that shall— 
(1) identify the purpose and scope of a nation-
ally integrated biosurveillance capability; 
(2) establish goals, objectives, priorities, mile-
stones, and performance measures to guide the devel-
opment of such capability; 
(3) define and prioritize costs, benefits, and re-
source and investment needs, with particular atten-
tion to leveraging existing resources; 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
(4) delineate Federal, State, local, tribal, and 
private roles and responsibilities; and 
(5) describe how the Strategy is integrated with 
related national strategies. 
(b) MATTERS FOR CONSIDERATION.—In developing the 
strategy required under subsection (a), the Special Assistant 
shall take into consideration— 
(1) the state of biosurveillance domestically and 
internationally; 
(2) material threat assessments and determina-
tions developed by the Secretary of Homeland Secu-
rity in accordance with the Project BioShield Act of 
2004 (Public Law 108–276) and the amendments 
made by that Act; 
(3) risk assessments consistent with section 2102 
of the Homeland Security Act of 2002, as amended by 
this Act; 
(4) reports on global trends produced by the Of-
fice of the Director of National Intelligence regarding 
the biological threat; 
(5) Intelligence Community needs as articulated 
in relevant intelligence strategies; 
(6) information available in biosurveillance sys-
tems and changes to information technology including 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
systems used commercially to allow for the incorpora-
tion and integration of this information; and 
(7) costs associated with establishing and main-
taining the necessary infrastructure to integrate bio-
surveillance systems. 
(c) IMPLEMENTATION PLAN.—In addition to the strat-
egy required under subsection (a), the Special Assistant 
shall publish an implementation plan for such strategy that 
includes benchmarks for measuring the success of the Strat-
egy. The implementation plan shall— 
(1) include a plan for advancing situational 
awareness of biological threats, by rapid detection 
and dissemination of biosurveillance information in 
real time, and through other means; 
(2) include a plan for fostering information 
sharing among national biosecurity and biodefense 
stakeholders— 
(A) to identify potential threats, reduce 
vulnerabilities, and improve collective response 
activities to, and investigations of, suspected bio-
logical attacks; 
(B) that addresses the type of information 
to be shared and how it will be shared; and 
(C) that identifies critical sensitivities to be 
protected; and 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
(3) include a plan for enhancing the capability 
of the Federal Government to rapidly identify, char-
acterize, localize, and track a biological event of na-
tional concern by integrating and analyzing data re-
lating to human health, animal, plant, food, and en-
vironmental monitoring systems (both national and 
international). 
(d) DEADLINE; SUBMISSION; UPDATES.—The Special 
Assistant shall— 
(1) publish the strategy, and submit it to the ap-
propriate congressional committees, by not later than 
1 year after the date of enactment of this Act; and 
(2) publish an implementation plan for such 
strategy not later than 2 years after the date of enact-
ment of this Act, and update the implementation plan 
at least once every 4 years. 
SEC. 104. COMPREHENSIVE CROSS-CUTTING BIODEFENSE 
BUDGET ANALYSIS. 
(a) IN GENERAL.—In order to enhance strategic plan-
ning, eliminate redundancies, identify capability gaps, and 
provide for greater transparency, the Special Assistant to 
the President for Biodefense, in coordination with the Di-
rector of the Office of Management and Budget, shall trans-
mit to the appropriate congressional committees, concurrent 
with the submission of the President’s annual budget to the 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with
Congress, a comprehensive cross-cutting biodefense budget 
analysis that delineates and integrates the biodefense ex-
penditure requests for the departments and agencies headed 
by the officials listed in subsection (c). 
(b) CONTENTS.— 
(1) IN GENERAL.—The comprehensive cross-cut-
ting biodefense budget analysis shall provide a de-
tailed, separate analysis, by budget function, by de-
partment or agency, and by initiative area (as deter-
mined by the Administration), for the prior fiscal 
year, the current fiscal year, and the fiscal years for 
which the budget is submitted, identifying the 
amounts 
of 
gross 
and 
net 
appropriations 
or 
obligational authority and outlays that contribute to 
biodefense, with separate displays for mandatory and 
discretionary amounts, including— 
(A) summaries of the total amount of such 
appropriations or obligational authority and 
outlays requested for biodefense; 
(B) an estimate of the current service levels 
of biodefense spending; and 
(C) an indication of how the Federal activi-
ties or accounts covered by the analysis support 
the activities delineated in the National Bio-
defense Plan under section 102(2). 
VerDate Mar 15 2010 
21:28 Nov 30, 2012
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6203
E:\BILLS\H2356.RH
H2356
mstockstill on DSK4VPTVN1PROD with